Novo Nordisk A/S buy knallfrosch44665
Start price
17.03.24
/
50%
€185.00
Target price
17.03.25
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 17.03.25. The prediction end date can be changed by knallfrosch44665 at any time.Novo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S | - | - |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by knallfrosch44665 for this prediction
In the thread Novo Nordisk A/S diskutieren
Buy Novo Nordisk A/S